A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2001
10/16/2001	US6303331 Vertebrate apoptosis gene: compositions and methods
10/16/2001	US6303321 Methods for diagnosing sepsis
10/16/2001	US6303318 Detecting urogenital hyperplasia; isolate proteases in sample, detecting and classify preferential proteases in sample, compare to control, amplified enzyme concentration indicates hyperplasia
10/16/2001	US6303136 For cell screening and implantation into a mammalian host
10/16/2001	US6303116 Genetically engineered retroviral vector particles capable of infecting non-dividing cells
10/11/2001	WO2001075454A2 Diagnosis and treatment of alzheimer's disease
10/11/2001	WO2001075440A2 Schizophrenia related genes
10/11/2001	WO2001075170A1 A functional assay of high-density lipoprotein
10/11/2001	WO2001075168A1 Control of a gene induced by oxidized lipids in human artery wall cells
10/11/2001	WO2001075164A2 Rna sequence-specific mediators of rna interference
10/11/2001	WO2001075135A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders
10/11/2001	WO2001075134A1 The adeno-associated virus which contains the growth hormone gene or related genes and their usage
10/11/2001	WO2001075114A2 Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
10/11/2001	WO2001075113A2 Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof
10/11/2001	WO2001075109A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001	WO2001075108A1 Human ion channel protein and polynucleotides encoding the same
10/11/2001	WO2001075104A1 Novel protein, dna thereof and process for producing the same
10/11/2001	WO2001075094A1 Application of myeloid-origin cells to the nervous system
10/11/2001	WO2001075092A2 CpG REDUCED PLASMIDS AND VIRAL VECTORS
10/11/2001	WO2001075082A1 DEOXYRIBONUCLEASE IIβ PROTEINS AND cDNAs
10/11/2001	WO2001075078A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
10/11/2001	WO2001075068A2 Secreted proteins and polynucleotides encoding them
10/11/2001	WO2001075066A2 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses
10/11/2001	WO2001075064A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
10/11/2001	WO2001074904A2 G-protein coupled receptors and nucleic acids encoding same
10/11/2001	WO2001074903A2 CD20/IgE-RECEPTOR LIKE MOLECULES AND USES THEREOF
10/11/2001	WO2001074902A2 Adenine binding g protein coupled receptors
10/11/2001	WO2001074900A2 Nuclear factor kb inducing factor
10/11/2001	WO2001074897A2 Protein amf-1 to amf-10 and nucleic acids encoding the same
10/11/2001	WO2001074863A2 Chlamydia antigens and corresponding dna fragments and uses thereof
10/11/2001	WO2001074861A2 Compositions and methods for tissue specific gene regulation therapy
10/11/2001	WO2001074859A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/11/2001	WO2001074856A2 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	WO2001074413A1 Medical devices suitable for gene therapy regimens
10/11/2001	WO2001074404A2 Compositions containing genetically modified lung cancer cells expressing a tgf-beta inhibitor
10/11/2001	WO2001074403A1 Combination of p53 gene and e1b-deleted p53 gene
10/11/2001	WO2001074385A1 Angiogenic onchocerca volvulus proteins and uses thereof
10/11/2001	WO2001074381A2 Calpain inhibitors in cancer treatment
10/11/2001	WO2001074379A2 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
10/11/2001	WO2001074346A2 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes
10/11/2001	WO2001074317A1 Methods of modulating hair growth
10/11/2001	WO2001074164A1 Methods of modulating hair growth
10/11/2001	WO2001074163A1 Compositions and methods of using hiv vpr
10/11/2001	WO2001048190A8 Therapeutic uses of lna-modified oligonucleotides
10/11/2001	WO2001044281A3 Human secretin-like g-protein coupled receptor
10/11/2001	WO2001036640A3 Human fgf-21 gene and gene expression products
10/11/2001	WO2001032873A8 Insulin-responsive sequence dna binding protein-1' (irsdbp-1), gene encoding it and uses thereof
10/11/2001	WO2001031003B1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response
10/11/2001	WO2001025269A3 Human g-protein coupled receptor
10/11/2001	WO2001023587A3 Serine protease
10/11/2001	WO2001021799B1 Traf4 associated cell cycle proteins, compositions and methods of use
10/11/2001	WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells
10/11/2001	WO2001020025A3 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
10/11/2001	WO2001018038A3 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis
10/11/2001	WO2001012154A3 Targeted lipid particles
10/11/2001	WO2001007625A3 Ehrlichia canis genes and vaccines
10/11/2001	WO2001004143A3 Prostase vaccine
10/11/2001	WO2000076556A3 High dose radionuclide complexes for bone marrow suppression
10/11/2001	WO2000065077A8 Triple hybrid amplicon vector systems to generate retroviral packaging lines
10/11/2001	WO2000062736A3 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/11/2001	WO2000053730A9 Medical preparations for the treatment of alpha-galactosidase a deficiency
10/11/2001	WO2000029549A3 Low oxygen culturing of cells
10/11/2001	WO2000026248A3 Tuberculosis diagnostic test
10/11/2001	US20010029617 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
10/11/2001	US20010029251 Administering cytomegalo virus protein
10/11/2001	US20010029250 Antiinflammatory agents; anticarcinogenic agents
10/11/2001	US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase
10/11/2001	US20010029246 Antiproliferative agent
10/11/2001	US20010029040 Agent for gene therapy of dilated cardomyopathy
10/11/2001	US20010029031 Polynucleotides encoding human sodium bicarbonate cotransporters
10/11/2001	US20010029020 In vitro determination of metastatic stomach, esophageal, and colorectal cancer from sampling cells outside of the colorectal track for gene transcript or protein
10/11/2001	US20010029019 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/11/2001	EP1144591A3 Low oxygen culturing of cells
10/11/2001	EP1144447A3 Tuberculosis diagnostic test
10/11/2001	CA2413211A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/11/2001	CA2408904A1 Compositions and methods of using hiv vpr
10/11/2001	CA2405549A1 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcription coupled repair genes
10/11/2001	CA2404896A1 Human ion channel protein and polynucleotides encoding the same
10/11/2001	CA2404890A1 Rna sequence-specific mediators of rna interference
10/11/2001	CA2404576A1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001	CA2404541A1 G-protein coupled receptors and nucleic acids encoding same
10/11/2001	CA2404526A1 Protein amf-1 to amf-10 and nucleic acids encoding the same
10/11/2001	CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	CA2404501A1 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
10/11/2001	CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	CA2404350A1 Control of a gene induced by oxidized lipids in human artery wall cells
10/11/2001	CA2404300A1 Medical devices suitable for gene therapy regimens
10/11/2001	CA2404257A1 Novel protein, dna thereof and process for producing the same
10/11/2001	CA2402586A1 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
10/11/2001	CA2401948A1 Cd20/ige-receptor like molecules and uses thereof
10/11/2001	CA2399399A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders
10/10/2001	EP1142910A1 Inhibitors for the formation of soluble human CD23
10/10/2001	EP1142907A1 THE POLYPEPTIDE DREAM, USED AS Ca2+ IONS-DEPENDENT TRANSCRIPTIONAL REGULATOR AND ITS GENE CODING THEREFOR
10/10/2001	EP1142902A2 3'-Derivatised oligonucleotide analogues with non-nucleotidic groups, their preparation and use
10/10/2001	EP1142591A1 Gene carriers
10/10/2001	EP1142590A1 Gene therapy for diabetic ischemic disease
10/10/2001	EP1142473A1 Method of acquiring immunological tolerance
10/10/2001	EP1141407A2 Method of identifying a psychotropic agent using differential gene expression
10/10/2001	EP1141395A1 Single nucleotide polymorphism in a pyruvate dehydrogenase kinase isoenzyme 2 (pdk2) in humans

1 ... 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 ... 870